Verrica Pharmaceuticals Statistics

Total Valuation

VRCA has a market cap or net worth of $60.95 million. The enterprise value is $45.56 million.

Market Cap	60.95M
Enterprise Value	45.56M

Important Dates

The last earnings date was Tuesday, August 12, 2025, after market close.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

VRCA has 9.25 million shares outstanding. The number of shares has increased by 63.50% in one year.

Current Share Class	9.25M
Shares Outstanding	9.25M
Shares Change (YoY)	+63.50%
Shares Change (QoQ)	+7.55%
Owned by Insiders (%)	61.61%
Owned by Institutions (%)	11.49%
Float	1.73M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.40
Forward PS	3.56
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	3.10
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-4.18

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-51.93%
Return on Invested Capital (ROIC)	-304.74%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	$207,099
Profits Per Employee	-$684,507
Employee Count	71
Asset Turnover	0.32
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -87.10% in the last 52 weeks. The beta is 1.92, so VRCA's price volatility has been higher than the market average.

Beta (5Y)	1.92
52-Week Price Change	-87.10%
50-Day Moving Average	6.64
200-Day Moving Average	7.03
Relative Strength Index (RSI)	50.22
Average Volume (20 Days)	52,067

Short Selling Information

The latest short interest is 149,764, so 1.62% of the outstanding shares have been sold short.

Short Interest	149,764
Short Previous Month	2.21M
Short % of Shares Out	1.62%
Short % of Float	8.67%
Short Ratio (days to cover)	2.07

Income Statement

In the last 12 months, VRCA had revenue of $14.70 million and -$48.60 million in losses. Loss per share was -$6.41.

Revenue	14.70M
Gross Profit	873,000
Operating Income	-37.85M
Pretax Income	-80.74M
Net Income	-48.60M
EBITDA	-37.14M
EBIT	-37.85M
Loss Per Share	-$6.41

Full Income Statement

Balance Sheet

The company has $15.40 million in cash and n/a in debt, giving a net cash position of $15.40 million or $1.66 per share.

Cash & Cash Equivalents	15.40M
Total Debt	n/a
Net Cash	15.40M
Net Cash Per Share	$1.66
Equity (Book Value)	-17.48M
Book Value Per Share	-1.71
Working Capital	36.78M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	5.94%
Operating Margin	-257.42%
Pretax Margin	-330.52%
Profit Margin	n/a
EBITDA Margin	-252.58%
EBIT Margin	-257.42%
FCF Margin	n/a

Dividends & Yields

VRCA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-63.50%
Shareholder Yield	-63.50%
Earnings Yield	-79.74%
FCF Yield	n/a

Analyst Forecast

The average price target for VRCA is $60.00, which is 810.47% higher than the current price. The consensus rating is "Hold".

Price Target	$60.00
Price Target Difference	810.47%
Analyst Consensus	Hold
Analyst Count	5
Revenue Growth Forecast (5Y)	105.22%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 25, 2025. It was a reverse split with a ratio of 1:10.

Last Split Date	Jul 25, 2025
Split Type	Reverse
Split Ratio	1:10

Scores

Altman Z-Score	n/a
Piotroski F-Score	2